Equities

Changmao Biochemical Engineering Co Ltd

  • Add to watchlist
  • Add to portfolio
  • Add an alert

Changmao Biochemical Engineering Co Ltd

Actions
  • Price (HKD)0.33
  • Today's Change0.00 / 0.00%
  • Shares traded180.00k
  • 1 Year change-22.35%
  • Beta0.8640
Data delayed at least 15 minutes, as of Feb 13 2026 06:45 GMT.
More ▼
Notice
Important Notice
Please note that effective 5th February, 2026 the Financial Times will no longer publish or present securities from the Nairobi Stock Exchange.

Profile data is unavailable for this security.

About the company

Changmao Biochemical Engineering Co Ltd is a China-based company principally engaged in the production and sale of organic acids products. The Company’s products include organic acids and their derivatives with four carbons, such as maleic anhydride, fumaric acid, maleic acid, L-malic acid, D-malic acid, DL-malic acid, DL-tartaric acid, L-aspartic acid and aspartame and others. The Company’s products are mainly used in food additives, chemical or medical intermediaries. The Company mainly operates its businesses in the domestic and overseas markets, including Europe, Asia Pacific and America.

  • Revenue in HKD (TTM)614.61m
  • Net income in HKD-85.13m
  • Incorporated1992
  • Employees533.00
  • Location
    Changmao Biochemical Engineering Co LtdNo. 1228Changjiang North RoadNew North DistrictCHANGZHOU 213034ChinaCHN
  • Phone+86 51 985776801
  • Fax+86 51 985776803
  • Websitehttps://www.cmbec.cn
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.